Cizumab Bevacizumab Injection

Name: Cizumab Bevacizumab Injection
Brand: Shashvat Pharmaceuticals
Price: 12000 INR
Availability: InStock

Price 12000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Cizumab Bevacizumab Injection Specification

Dosage Form
Solution for Infusion

Salt Composition
Bevacizumab

Indication
Various cancers (e.g., metastatic colorectal cancer, non-small cell lung cancer, etc.)

Feature
Monoclonal antibody, anti-VEGF agent

Ingredients
Bevacizumab

Application
Intravenous infusion

Physical Color/Texture
Clear to slightly opalescent, colorless to pale brown

Fermentation Smell
Odorless

Storage Instructions
Store at 2-8C, do not freeze

Shelf Life
24 months

Strength
400 mg

Preservation
Refrigerate, protect light

Container Type
Glass vial

Sterility
Sterile solution

Packaging Type
Vial

Dilution Required
Yes, before use

Intended Use
Oncology therapy

Volume
16 ml

Route
Intravenous

Cizumab Bevacizumab Injection Trade Information

Minimum Order Quantity
1 Vial

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Cizumab Bevacizumab Injection

Don't miss this Last Chance to secure the gilt-edged Cizumab Bevacizumab Injection-an industry-leading, top-drawer solution for oncology therapy. Formulated with the finest Bevacizumab (400 mg/16 ml), this sterile, intravenous monoclonal antibody is indicated for a range of cancers, including metastatic colorectal and non-small cell lung cancer. Packaged in a glass vial for optimal preservation, this product must be refrigerated and protected from light. Buy online now at the best deal-perfect for medical suppliers and oncology centers across India. Dilution is required before use.

Advanced Oncology Solution for Targeted Cancer Therapy

Cizumab Bevacizumab Injection is extensively used as a potent monoclonal antibody, primarily in the treatment of various cancers such as metastatic colorectal and non-small cell lung cancers. Its specific use is tailored for intravenous infusion, making it suitable for hospital and clinical settings. The general use spans targeted anti-VEGF (vascular endothelial growth factor) inhibition, which aids in slowing tumor progression. This top-drawer injection is ideal for oncologists requiring a targeted, evidence-backed cancer therapy.

Reliable Supply, Quick Arrival, and Accessible Samples Offered

Our Cizumab Bevacizumab Injection is available for swift dispatching to ensure timely arrival, maintaining the highest quality standards. With a strong supply ability, medical institutions can secure the sale price for bulk orders and prompt delivery times across India. Samples are available upon request for healthcare professionals to evaluate before full-scale acquisition. Choose supplier and trader support dedicated to smooth, hassle-free logistics so you can focus on patient care.

FAQ's of Cizumab Bevacizumab Injection:

Q: How should Cizumab Bevacizumab Injection be stored for maximum potency?

A: Store the injection in a refrigerator at 2-8C and do not freeze. Ensure it is protected from light to maintain its efficacy.

Q: What cancers can be treated with Cizumab Bevacizumab Injection?

A: This injection is indicated for various cancers, including metastatic colorectal cancer and non-small cell lung cancer, among others as determined by your oncologist.

Q: When should Cizumab Bevacizumab Injection be diluted before use?

A: Dilution is required immediately before intravenous infusion, as per the recommended guidelines provided in the product instructions.

Q: Where can I buy Cizumab Bevacizumab Injection online in India?

A: You can buy this top-drawer oncology product online through authorized medical suppliers or traders specialized in anti-VEGF therapies across India.

Q: What is the process for receiving a sample of Cizumab Bevacizumab Injection?

A: To obtain a sample, medical professionals can contact the supplier or trader to request a sample for evaluation prior to placing a larger order.

Q: What benefits does Cizumab Bevacizumab Injection offer to oncology patients?

A: It acts as a monoclonal antibody targeting VEGF, helping slow the growth of tumors and offering advanced, targeted therapy as part of a patient's cancer treatment plan.

Tell us about your requirement